Lawrence Tallon today (1 April 2025) begins his role as Chief
Executive Officer of the Medicines and Healthcare products
Regulatory Agency (MHRA).
Lawrence brings a strong focus on patient safety, innovation and
partnership working, which have been central to his previous
roles including as Deputy Chief Executive of Guy's and St Thomas'
NHS Foundation Trust since March 2020.
Lawrence said: “I am delighted to be joining the MHRA, which
plays a vital role in ensuring people across the UK and the NHS
have access to safe and effective medicines and medical devices.
“My priorities are patient safety, improving patient access to
new medicines and medical devices through risk-proportionate
regulation, innovation and growth, and building partnerships in
the UK and internationally.”
Lawrence has also been Managing Director of the Shelford Group,
which represents some of England's leading NHS teaching
hospitals. This experience has given him valuable insight into
the challenges and opportunities facing modern healthcare and
life science systems.
Prior to this he served as Director of Strategy, Planning and
Performance at University Hospitals Birmingham NHS Foundation
Trust and worked within the Department of Health and Social Care
alongside ministers and NHS leaders.
Lawrence succeeds Dr June Raine DBE, who is retiring after
leading the MHRA since 2019, having steered the
agency through the COVID-19 pandemic and the UK's exit from
the European Union.
Lawrence was announced as the
new MHRA CEO in March 2025 by the Department of Health and Social
Care.
